Balance Sheet Accounts and Supplemental Disclosures - Summary Of Prepaid Expenses and other Current (Details) - USD ($) $ in Thousands |
Jun. 30, 2026 |
Dec. 31, 2025 |
|---|---|---|
| Prepaid Expense, Current [Abstract] | ||
| Receivable from AnaptysBio | $ 4,226 | $ 0 |
| Prepaid clinical development | 2,470 | 2,851 |
| Receivable from option exercises | 848 | 29 |
| Other current assets | 2,183 | 1,882 |
| Total prepaid expenses and other current assets | $ 9,727 | $ 4,762 |
| X | ||||||||||
- Definition Prepaid clinical development No definition available.
|
| X | ||||||||||
- Definition The amount owed to the reporting entity by counterparties in securitized loan transactions. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of current assets classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount due from customers for fees and charges arising from transactions related to the entity's brokerage activities and operations. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|